发明名称 FORMULATIONS AND METHODS FOR TREATMENT OF METABOLIC SYNDROME
摘要 Formulations and methods of providing an orally-active anti-metabolic disease Fixed Dose Combinations (FDC) for use as personalized medicine to treat different components of the Metabolic Syndrome or Insulin resistance syndrome such as Type II diabetes, Hypertension, Hyperlipidemia and Obesity are disclosed. Pharmaceutical compositions of anti-inflammatory and pancreatic beta-cell centric drug formulations and methods comprising of NSAIDS in general and selective Cox-2 inhibitors in particular and one or more anti-T2DM or anti-hypertensive or anti-hyperlipidemic or anti-obesity drugs formulated to exhibit pre-determined modified release kinetics to achieve therapeutic as well as kinetic synergies are disclosed.
申请公布号 US2016213694(A1) 申请公布日期 2016.07.28
申请号 US201615063000 申请日期 2016.03.07
申请人 ARKAY Therapeutics, LLC 发明人 KUMAR Ravi Seshagirirao
分类号 A61K31/635;A61K31/41;A61K31/155 主分类号 A61K31/635
代理机构 代理人
主权项 1. A pharmaceutical formulation comprising a therapeutically effective amount of a Type II diabetes drug, an anti-inflammatory drug, and an angiotensin II type 1 receptor blocker.
地址 East Windsor NJ US